about
Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.Radiation Exposure in Endovascular Infra-Renal Aortic Aneurysm Repair and Factors that Influence It.Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activityIntracellular trafficking of AIP56, an NF-κB-cleaving toxin from Photobacterium damselae subsp. piscicidaThe apoptogenic toxin AIP56 is a metalloprotease A-B toxin that cleaves NF-κb P65The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.Comparison between CDC and WHO BMI z-score and their relation with metabolic risk markers in Northern Portuguese obese adolescents.Arterial stiffness and influences of the metabolic syndrome: a cross-countries studyA 10-Year Retrospective Analysis of Methyl Aminolevulinate Photodynamic Therapy Consultation at the Hospital de Braga.Endovascular Abdominal Aneurysm Repair in Women: What are the Differences Between the Genders?Institutional Impact of EVAR's Incorporation in the Treatment of Abdominal Aortic Aneurysm: a 12 Years' Experience Analysis.Impact of Endovascular Aortic Aneurysm Repair in a Renal Transplantation Program.Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy.Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone.The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.Asthma control, quality of life, and the role of patient enablement: a cross-sectional observational study.Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging.Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia.Is Age a Determinant Factor in EVAR as a Predictor of Outcomes or in the Selection Procedure? Our Experience.Endovascular Treatment of Internal Iliac Artery Aneurysms: Single Center Experience.Iodine status of pregnant women and their progeny in the Minho Region of Portugal.Benchmarking clinical practice in surgery: looking beyond traditional mortality rates.The rationale/design of the Guimarães/Vizela study: a multimodal population-based cohort study to determine global cardiovascular risk and disease.Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.Association between functional EGF+61 polymorphism and glioma risk.Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.An epidemiological study determining blood pressure in a Portuguese cohort: the Guimarães/Vizela study.Dogs mean arterial pressure and heart rate responses during high propofol plasma concentrations estimated by a pharmacokinetic model.The choroid plexus response to peripheral inflammatory stimulus.Evidence for abnormal early development in a mouse model of Rett syndrome.Impact of EGFR genetic variants on glioma risk and patient outcome.Mutation Frequency of Three Neurodegenerative Lysosomal Storage Diseases: From Screening to Treatment?Salt intake in children 10-12 years old and its modification by active working practices in a school garden.An adaptive sharing elitist evolution strategy for multiobjective optimization.A twenty-year survey of dermatophytoses in Braga, Portugal.Pulse wave velocity distribution in a cohort studyPsychomotor Development of Children from an Iodine-Deficient RegionX-linked adrenoleukodystrophy in patients with idiopathic addison diseaseCo-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium?
P50
Q30703360-CAB02A4D-EAA3-4C47-A05E-50716B23F8DAQ31155800-6E83AE67-E47B-4373-B40F-75F750667E5CQ33609287-39B49458-260D-4301-B91E-002E95E806F1Q34064205-56529F65-2718-41D9-BFAD-7AE62FF47C60Q34595840-6D58FFFD-F562-4EC4-9290-817311DD5F16Q34611109-B187C9D3-A056-4401-A999-5FD09D13D0BFQ34988362-25ABE1A8-9C2D-4AE4-952E-D3AAE06B27C8Q35594998-9279EC7F-08E6-4CAE-8A5A-CC26C028DFDBQ35994619-157ABF76-B36A-4B4C-B14A-674E4145E9FDQ36999991-69243089-576D-401C-91DC-38A9539087B0Q37336389-744D9CD4-6FDD-4C23-AFB6-333C4F063E2FQ37336465-8C8B0D8E-CF94-4DBD-A364-F1E36E4F9D28Q38891211-E7C33C8C-9F44-4362-B19E-610D13A6FBA5Q39295814-BF7CFC16-F2DC-4858-9634-A73DC84B120FQ39325281-3BB1C4EA-C47F-4006-B469-86F0AD399CEAQ39888147-E3F77F38-D421-4A42-BDDC-E6C13A4CE02BQ40106538-A0E24D42-6310-4202-8016-D11C6141C7BFQ40577620-FCC5F648-B161-476E-908A-4736CCE98BA8Q41244721-380CA9EF-31CA-4EF3-B2B1-4125C0457E2EQ41451509-69B2BB46-CE8A-4F16-8E35-DD0553269CBDQ41451516-E6288632-125B-4A75-B22E-88EEF7FE543FQ44175168-A0B29184-2B4B-40B1-8626-71DEC82118B2Q44558468-8437B134-8A42-4951-A81A-F2FF56283DC2Q45910548-98B91D4F-8F6E-4509-83D1-F514635E322BQ47972274-52C47373-DF3F-4EEB-9A05-02DDC65A046BQ48181818-BE26025D-A7B8-49B0-9136-72CAA366EB82Q48182278-DE54BE85-9B43-4460-8288-72EC23C527FAQ48285758-DC2A69A2-1679-4E00-8F14-A575029E048EQ48291788-59513DBA-6A3B-4398-832E-1D8588958C31Q48385819-02550C2A-26EA-4E9C-B8D3-388E6F9CB846Q48438909-4BAD47A7-EA85-48E3-B6BE-DF89472869DFQ48870888-515E4F2C-0561-40BF-871A-61E0C5C3E775Q50040328-6C6388EF-2B94-44C6-A4DE-EB7E3A728781Q50765695-7962FBA7-074A-4921-95C0-B0F4BD0A0D9CQ52007776-1D98C348-C772-48E4-8E2D-FEF4A29BD89BQ52805346-7F10D11C-99A6-48D5-9C5D-77E86C5732DFQ57966428-55DD4DD2-827D-4EC5-B7B5-5A1CA6DF856CQ57970226-15D8C79B-2B33-406D-A580-E815ABBD6D7AQ58278277-40C81339-40C2-4BB8-A7EA-A9711B016AC2Q60906145-D28ED20D-6919-42B4-AEC5-9E4211965FCB
P50
description
researcher ORCID: 0000-0002-2470-0795
@en
name
Pedro Oliveira
@ast
Pedro Oliveira
@en
Pedro Oliveira
@es
Pedro Oliveira
@nl
type
label
Pedro Oliveira
@ast
Pedro Oliveira
@en
Pedro Oliveira
@es
Pedro Oliveira
@nl
prefLabel
Pedro Oliveira
@ast
Pedro Oliveira
@en
Pedro Oliveira
@es
Pedro Oliveira
@nl
P106
P1153
57104456500
7102098106
P21
P2456
P31
P496
0000-0002-2470-0795